“…The key factors for increased likelihood of inhospital death were receipt of inpatient palliative care (OR = 1.85), chemotherapeutic treatments in the last 30 days of life (OR = 1.61) and comorbid Congestive Heart Failure (OR = 1.21), and Renal Disease (OR = 1.19). In contrast, higher care level (OR = 0.16), nursing home residency (OR = 0.25) and receipt of outpatient palliative care (OR = 0.25) were associated with a reduced likelihood. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Carbonic anhydrase inhibitors block renal bicarbonate reabsorption, and thus reverse metabolic alkalosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Patients with history of diabetes, cardiac, renal, and hepatic disease as well as pregnant women were excluded. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…CONCLUSIONS: GH therapy increases α-Klotho concentrations in subjects with normal renal function or stage 3 CKD. A larger follow-up study is needed to determine whether the effect size is different between both groups or in patients with more severe CKD. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Information regarding end-stage renal disease (ESRD) was investigated from the Korean Society of Nephrology registry. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Pegues, DaVita / Total Renal Care: Consultant, Consulting fee.…”
Enlace del recurso
Enlace del recurso

“…Exclusion criteria were history of renal dysfunction, chronic hepatitis B (HBV), HIV, pregnancy, and indications for postexposure prophylaxis. …”
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Antiviral prophylaxis to prevent PTLD remains controversial, but some data suggest that valganciclovir or ganciclovir ([val]ganciclovir) use in EBV high-risk pediatric renal transplants reduces EBV viremia. We evaluated the impact of [val]ganciclovir on EBV viremia and post-transplant lymphoproliferative disease (PTLD) in pediatric nonrenal SOT recipients. …”
Enlace del recurso
Enlace del recurso

“…In this cohort we sought to understand possible mechanisms for lower BMC by comparing markers of bone metabolism and renal function with TDF exposure in HEU neonates. …”
Enlace del recurso
Enlace del recurso

“…If clients believed that they were at substantial risk of HIV and were interested in PrEP, they could receive PrEP after screening that included HIV and renal function testing. Eligible clients received a 30-day supply of daily oral tenofovir-emtricitabine costing 800 Baht (30 USD), and completed a baseline computer-assisted self-interview (CASI) on knowledge and behaviors. …”
Enlace del recurso
Enlace del recurso

“…We present a case of pharmacokinetics (PK) of ganciclovir in an immunocompromised patient with respiratory failure requiring veno-venous ECMO support without continuous renal replacement therapy (CRRT). A 6-year old with a stage IV rhabdoid tumor s/p autologous bone marrow transplant rescue after chemotherapy 80 days prior to illness, developed acute respiratory failure. …”
Enlace del recurso
Enlace del recurso

“…METHODS: A retrospective cohort analysis of pediatric patients aged 2–17 years with first cystitis or pyelonephritis and without renal/anatomic abnormality was performed using claims and eligibility data from Truven Health MarketScan Database for 2013–2015. …”
Enlace del recurso
Enlace del recurso

“…At baseline, patients who received AZT were more likely to have renal dysfunction (34.1% vs. 18.2%, P = 0.046), receive synergistic antimicrobials (61% vs. 28.4%, P < 0.001) and had a longer pre-infection LOS (1 day [0–2] vs. 0 [0–1], P = 0.032) compared with those who received CEP. …”
Enlace del recurso
Enlace del recurso

“…Despite having similar baseline Charlson comorbidity scores, cases were more likely to return to surgery within 3 months (odds ratio, OR 6.31; 95% CI, 1.29–30.74), require renal replacement therapy (OR 18.54, 2.36–145.6), total parenteral nutrition (OR 33.0, 6.60–262.37) and corticosteroids (OR 18.78, 4.5–103.9). …”
Enlace del recurso
Enlace del recurso

“…Toxicity requiring a therapeutic change of an antiviral prophylactic agent was more common in HR (25.7%) vs. SR (8.9%) patients. Renal insufficiency was the most common reported toxicity, followed by electrolyte wasting (figure). …”
Enlace del recurso
Enlace del recurso

“…Pegues, DaVita / Total Renal Care: Consultant, Consulting fee.…”
Enlace del recurso
Enlace del recurso

“…There was a trend toward more pre-existing renal failure (39% vs. 24%; P = 0.09) in C. auris patients and during the two weeks prior to candidemia, they were more likely to have central lines (84% vs. 54%; P ≤ 0.001). …”
Enlace del recurso
Enlace del recurso

“…We compared demographics (age, sex, and race), co-morbid conditions (BMI, diabetes, immunosuppression, renal disease, and antibiotic use), and clinical characteristics (joint age, wound factors, laboratory data, previous joint surgeries, and previous PJI) between fungal and bacterial PJI groups using chi square/Fisher’s exact or Wilcoxon rank-sum test. …”
Enlace del recurso
Enlace del recurso

“…Eligible patients were: 1) aged ≥18 years old, 2) admitted to an acute facility in a NSW public hospital between 30th June 2005 and 1st July 2014, and 3) admitted with either cardiovascular disease, chronic respiratory disease, diabetes or renal disease. The primary composite outcome was unplanned readmission or death within 28 days of discharge. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Exclusion criteria were hepatic dysfunction; renal dysfunction; ongoing infectious diseases; solid or hematologic tumors; severe insulin-dependent diabetes; body mass index of < 17 or > 40 kg/m(2); pregnancy or lactation; antibiotic, corticosteroid, or other immunosuppressive therapy; vancomycin or nonsteroidal anti-inflammatory drug therapy in the previous 2 wk; chemotherapy or radiation therapy in the previous 6 mo; allergy to vancomycin or cefazolin; drug abuse; cardiac surgery in the previous 6 mo; previous or scheduled organ transplantation; preoperative stay in the intensive care unit for more than 24 h; emergency procedure or lack of adequate preparation for surgery; and participation in another trial. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso